CTSC and rheumatoid arthritis: In this study, we assessed the efficacy of a potent and highly selective DPP-1 inhibitor, brensocatib, in two well established RA models – rat collagen-induced arthritis (CIA) and mouse collagen antibody-induced arthritis (CAIA).